Make an appointment with a cancer specialist today.
Call us at 800-KARMANOS (800-527-6266)


Dr. Philip A. Philip Accepts Invitation to Pancreatic Cancer Action Network's Medical Advisory Board

Philip A. Philip, M.D., Ph.D., F.R.C.P., leader of the Gastroenterology and Neuroendocrine Tumors Multidisciplinary Team at the Barbara Ann Karmanos Cancer Institute, has been named a new member of the Pancreatic Cancer Action Network’s Medical Advisory Board.

Dr. Philip joins Joseph M. Herman, M.D., M.Sc. of Johns Hopkins University; George A. Fisher Jr., M.D., Ph.D. of Stanford University; and James Farrell, M.D., of Yale University, as new members.

Julie Fleshman, president and CEO of the Pancreatic Cancer Action Network, said Dr. Philip and his colleagues “bring a great wealth of expertise to the organization and their active participation will further strengthen our programs to support pancreatic cancer patients. The role of the Medical Advisory Board is essential as the Pancreatic Cancer Action Network works to double the survival for pancreatic cancer by 2020.”

The Medical Advisory Board includes clinicians who specialize in the care of people with pancreatic cancer. The board advises the organization on specific medical and clinical aspects of pancreatic cancer as they relate to the network’s programs. Members come from a variety of cancer centers, including M.D. Anderson Cancer Center in Houston; Vanderbilt-Ingram Cancer Center in Nashville; H. Lee Moffitt Cancer Center in Tampa; and Memorial Sloan-Kettering in New York City, among others.

The Pancreatic Cancer Action Network, based in Manhattan Beach, Calif., is a national organization that strives to bring hope to individuals with pancreatic cancer through research, patient support, community outreach and advocacy for a cure. It has the goal of increasing the survival rate for people diagnosed with pancreatic cancer through its initiative, “The Vision of Progress: Double the Pancreatic Cancer Survival Rate by 2020.” Other goals include heightening awareness of the disease; raising funds for comprehensive private research; and advocating for dedicated federal research to advance early diagnostics, better treatments, and increased chances of survival.

To read an article about Dr. Philip’s invitation to the medical advisory board, click

© 2014 Karmanos Cancer Institute Pencil
The Barbara Ann Karmanos Cancer Center is accredited by The Joint Commission.
If members of the public have any quality-of-care or safety concerns, they may notify The Joint Commission at 630-792-5800.